Alzheimer's Disease Market Research Reports & Industry Analysis
A gradual loss of neurons later in adulthood does not result in significant alteration in brain function during the usual life span. However, the older one gets, the greater the neurologic impairment. Excessive neuronal degeneration in adulthood is called Alzheimer’s disease or senile dementia and is distinguished from the normal changes in aging. Alzheimer’s disease is a progressive disease which results in death of the brain cells causing memory lapses, behavioral issues, and disruption of thinking processes. The disease is considered fatal. Age and generic inheritance are the two key risk factors for developing Alzheimer’s disease. These are also risk factors that are not preventable. However, other preventable risk factors have been linked to the development of AD, including environment, diet, and overall general health. A combination of risk factors is often responsible for the disease.
Alzheimer’s disease is estimated to affect up to 6% of the population over 65. Life expectancy has been increasing around the world due to advances in healthcare, medical research, sanitation, and nutrition. This provides a setting for a higher number of Alzheimer’s disease patients in the future as the population continues to add years to their life.
Alzheimer's Disease Industry Research & Market Reports
-
Global Early Diagnosis Kit for Alzheimer's Disease Market Research Report 2024
... million by 2030, witnessing a CAGR of 8.33% during the forecast period 2024-2030. North American market for Early Diagnosis Kit for Alzheimer’s Disease is estimated to increase from $ 33.39 million in 2023 to reach ... Read More
-
Alzheimer’s Disease Treatment Global Market Report 2024
... AntagonistsCovering: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Bayer AG; Novartis AG Alzheimer’s Disease Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information ... Read More
-
Global Alzheimer's Disease Diagnostic Market Growth (Status and Outlook) 2024-2030
... demand in downstream market, the Alzheimer's Disease Diagnostic is forecast to a readjusted size of US$ 3943.3 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential ... Read More
-
Alzheimer's Disease Diagnostics and Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029
... is expected to reach USD 9.78 billion by 2029, growing at a CAGR of 5.06% during the forecast period (2024-2029). The emergence of the COVID-19 pandemic impacted the Alzheimer's disease diagnostics and therapeutics market, as ... Read More
-
Global Blarcamesine Market, By Route of Adminsitration (Oral, Parenteral), By Application (Alzheimer's Disease, Parkinson's Disease , Dementia, Rett Syndrome, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).
... Pacific, Latin America, Middle East and Africa). Global blarcamesin market will be valued at US$ 822.2 Mn in 2026 and is expected to reach US$ 992.4 Mn by 2031, exhibiting a compound annual growth rate ... Read More
-
Global Alzheimer's Drugs Market Growth 2024-2030
... Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Alzheimer's Drugs market. Alzheimer's Drugs ... Read More
-
US Alzheimer's Disease Diagnostic Market Research Report Forecast to 2040
... Alzheimer's, is a progressive and degenerative brain disorder that primarily affects cognitive functions, especially memory, thinking, and behavior. It is the most common cause of dementia in older adults. The disease is characterized by the ... Read More
-
Global Elderly Care Services Market: Focus on Services, Application, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033
... the diverse needs of older individuals or senior citizens. The core objective of elderly care revolves around addressing the social and personal needs of aging individuals, fostering an environment that allows them to maintain their ... Read More
-
Alzheimer's Disease Diagnostics & Therapeutics Market by Product (Diagnostics, Therapeutics), Disease Stage (Early, Moderate, Severe), End-User - Global Forecast 2024-2030
... 2023 and expected to reach USD 7.26 billion in 2024, at a CAGR 8.00% to reach USD 11.57 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Alzheimer's Disease ... Read More
-
Neurological Biomarkers Market by Type (Genomic, Imaging, Metabolomic), Application (Alzheimer’s Disease, Autism Spectrum Disorders, Multiple Sclerosis), End-user - Global Forecast 2024-2030
... expected to reach USD 10.24 billion in 2024, at a CAGR 14.05% to reach USD 22.56 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Neurological Biomarkers Market. It ... Read More
-
Dementia Drugs Market by Indications (Alzheimer's Disease, Lewy Body Dementia, Parkinsons Disease Dementia), Drug Class (Cholinesterase Inhibitors, Glutamate Inhibitors, MAO Inhibitors) - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 10.78 billion in 2024, at a CAGR 10.39% to reach USD 19.58 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Central Nervous System Biomarkers Market by Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease Indication (Alzheimer’s Disease, Multiple Sclerosis, Parkinson’s Disease), Application, End-User - Global Forecast 2024-2030
... estimated at USD 4.37 billion in 2023 and expected to reach USD 4.81 billion in 2024, at a CAGR 10.39% to reach USD 8.73 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Neurology Endoscopy Devices Market by Product (Accessories, Endoscopes, Operative Devices), Indication (Alzheimer’s Disorders, Brain Cancer, Brain Tumor), Usability, End User, Application - Global Forecast 2024-2030
... 5.19 billion in 2023 and expected to reach USD 5.56 billion in 2024, at a CAGR 7.22% to reach USD 8.46 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
South & Central America Deep Brain Simulation Market Forecast to 2030 - Regional Analysis - by Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator, and Software and Accessories), Application (Parkinson\'s Disease, Tremor, Dystonia, Epilepsy, Alzheimer\'s Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others)
... Dystonia, Epilepsy, Alzheimer\'s Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others) The South & Central America deep brain simulation market is expected to grow from US$ 27.53 million in ... Read More
-
Middle East & Africa Deep Brain Simulation Market Forecast to 2030 - Regional Analysis - by Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator, and Software and Accessories), Application (Parkinson\'s Disease, Tremor, Dystonia, Epilepsy, Alzheimer\'s Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others)
... Dystonia, Epilepsy, Alzheimer\'s Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others) The Middle East & Africa deep brain simulation market is expected to grow from US$ 25.64 million in ... Read More
-
Brain Biomarkers Market by Product (Biomarker Analyzers, Biomarker Test Kits), Indication (Alzheimer's Disease, Huntington's Disease, MND & ALS), End-Users, Application - Global Forecast 2024-2030
... in 2023 and expected to reach USD 10.54 billion in 2024, at a CAGR 17.90% to reach USD 28.33 billion by 2030. Global Brain Biomarkers Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Alzheimer's Disease Drugs Market by Drug Class (Cholinergic, Combined Drug, Memantine), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) - Global Forecast 2024-2030
... in 2023 and expected to reach USD 4.74 billion in 2024, at a CAGR 10.10% to reach USD 8.45 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Alzheimer's ... Read More
-
Neuroprotection Market by Product (Apoptosis Inhibitors, Free Anti-Inflammatory Agents, Glutamate Antagonists), Treatment (Alzheimer's Disease, Amyotrophic Lateral Sclerosis, Brain Injury), Application - Global Forecast 2024-2030
... 2023 and expected to reach USD 16.20 billion in 2024, at a CAGR 9.86% to reach USD 28.52 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Neuroprotection Market. ... Read More
-
Alzheimer's Drugs Global Market Report 2024
... AbbVie Inc.; Daiichi Sankyo Company Limited; F Hoffmann-La Roche AG; Merck & Co Inc.; Novartis AG Alzheimer's Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the ... Read More
-
Dementia Associated with Alzheimer's Disease Market (Drug Class: Cholinergic/Cholinesterase Inhibitors, Memantine, Combined Drugs, Others; Distribution Channel: Hospital Pharmacies, Retail, Online Sales) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2023-2031
... Alzheimer's Disease Market – Scope of Report TMR’s report on the global dementia associated with Alzheimer’s disease market studies the past as well as the current growth trends and opportunities to gain valuable insights of ... Read More
-
Neurological Biomarkers Market Size, Share & Trends Analysis Report By Application (Alzheimer’s, Parkinson’s, Multiple Sclerosis, Autism), By Type, By End-use, By Region, And Segment Forecasts, 2024 - 2030
... global neurological biomarkers market size is expected to reach USD 18.75 billion by 2030, expanding at a CAGR of 12.89% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increased ... Read More
-
Alzheimer Disease Drugs Companies in China
... expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in ... Read More
-
Alzheimer Disease Drugs Markets in China
... Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's ... Read More
-
Alzheimer Disease Drugs Industry Forecasts - China Focus
... of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the ... Read More
-
Global Alzheimer's Disease Therapeutics Market 2024-2028
... alzheimer's disease therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
Research Assistance
